[Use of a beta blocker in a traumatic apallic syndrome].
D000319:Adrenergic beta-Antagonists / Q000627:therapeutic use*; D000328:Adult; D001786:Blood Glucose / Q000378:metabolism; D001930:Brain Injuries / Q000188:drug therapy*; D001933:Brain Stem / Q000293:injuries; D003128:Coma / Q000188:drug therapy*; D003647:Debrisoquin / Q000627:therapeutic use; D004359:Drug Therapy, Combination; D004734:Energy Metabolism / Q000187:drug effects; D006339:Heart Rate / Q000187:drug effects; D006801:Humans; D008297:Male; D008636:Mesencephalon / Q000293:injuries; D009638:Norepinephrine / Q000097:blood
D000319:Adrenergic beta-Antagonists; D001786:Blood Glucose; D003647:Debrisoquin; D009638:Norepinephrine
Verwendung der Betablocker beim traumatischen apallischen Syndrom.